Crossmark

Atranorin inhibits NLRP3 inflammasome activation by targeting ASC and protects NLRP3 inflammasome-driven diseases

Published Online: 2023-03-24

Published Print: 2023-08

Authors

Wang, Hao-yu

Lin, Xi

Huang, Guan-gen

Zhou, Rong

Lei, Shu-yue

Ren, Jing

Zhang, Kai-rong

Feng, Chun-lan

Wu, Yan-wei

Tang, Wei
License Information

Text and Data Mining valid from 2023-03-24

Version of Record valid from 2023-03-24
More Information

Article History

Received: 7 November 2022

Accepted: 9 January 2023

First Online: 24 March 2023

Competing interests

: The authors declare no competing interests.

Document is current